Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radu Marches

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Cancer|September 24, 2004
Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cellsRadu Marches, Jonathan W Uhr
Cell Cycle (Georgetown, Tex.)|August 25, 2006
Cancer dormancy: from mice to manRadu Marches, Richard Scheuermann, Jonathan Uhr
Journal of Theoretical Biology|October 11, 2005
Mathematical models of the fate of lymphoma B cells after antigen receptor ligation with specific antibodiesTomás Alarcón, Radu Marches, Karen M Page
Blood|March 6, 2004
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell lineMaria-Ana Ghetie, Radu Marches, Stephanie Kufert, et al.
Frontiers in Immunology|September 19, 2022
The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathwaysParakkal Jovvian George, Radu Marches, Djamel Nehar-Belaid, et al.
Nanotechnology|January 25, 2011
The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cellsRadu Marches, Carole Mikoryak, Ru-Hung Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivoCamelia I Spiridon, Maria-Ana Ghetie, Jonathan Uhr, et al.
International Journal of Cancer|June 19, 2009
Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodiesRadu Marches, Pavitra Chakravarty, Inga H Musselman, et al.
Plos Pathogens|December 5, 2025
The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGFβMichael J Johnson, Megan Crotteau, Debashis Ghosh, et al.
Aging Cell|February 25, 2023
Transcriptional activation of Jun and Fos members of the AP-1 complex is a conserved signature of immune aging that contributes to inflammagingEmin Onur Karakaslar, Neerja Katiyar, Muneer Hasham, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Cancer|September 24, 2004
Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cellsRadu Marches, Jonathan W Uhr
Cell Cycle (Georgetown, Tex.)|August 25, 2006
Cancer dormancy: from mice to manRadu Marches, Richard Scheuermann, Jonathan Uhr
Journal of Theoretical Biology|October 11, 2005
Mathematical models of the fate of lymphoma B cells after antigen receptor ligation with specific antibodiesTomás Alarcón, Radu Marches, Karen M Page
Blood|March 6, 2004
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell lineMaria-Ana Ghetie, Radu Marches, Stephanie Kufert, et al.
Frontiers in Immunology|September 19, 2022
The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathwaysParakkal Jovvian George, Radu Marches, Djamel Nehar-Belaid, et al.
Nanotechnology|January 25, 2011
The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cellsRadu Marches, Carole Mikoryak, Ru-Hung Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivoCamelia I Spiridon, Maria-Ana Ghetie, Jonathan Uhr, et al.
International Journal of Cancer|June 19, 2009
Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodiesRadu Marches, Pavitra Chakravarty, Inga H Musselman, et al.
Plos Pathogens|December 5, 2025
The recombinant zoster vaccine induces trained immunity in monocytes through persistent downregulation of TGFβMichael J Johnson, Megan Crotteau, Debashis Ghosh, et al.
Aging Cell|February 25, 2023
Transcriptional activation of Jun and Fos members of the AP-1 complex is a conserved signature of immune aging that contributes to inflammagingEmin Onur Karakaslar, Neerja Katiyar, Muneer Hasham, et al.
Pageof 4